|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | (2006.01) |
| A61K 47/36 | (2013.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61K 9/7007 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 31/137 | (2013.01) | ||
| A61K 31/135 | (2006.01) | ||
| A61K 31/135 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) |
| (11) | Patento numeris | 3796896 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19726391.6 |
| Europos patento paraiškos padavimo data | 2019-05-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-03-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-12-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2019/063376 |
| Data | 2019-05-23 |
| (87) | Numeris | WO 2019/224323 |
| Data | 2019-11-28 |
| (30) | Numeris | Data | Šalis |
| 201808462 | 2018-05-23 | GB |
| (72) |
BOYER, Scott , SE
CAI, Shengzhen , SE
HÜBINETTE, Fredrik , SE
INGEMARSSON, Leif , SE
|
| (73) |
Klaria Pharma Holding AB ,
Virdings Allé 2, 754 50 Uppsala,
SE
|
| (54) | PHARMACEUTICAL FORMULATION OF ADRENALINE |
| PHARMACEUTICAL FORMULATION OF ADRENALINE |